Mon.Aug 21, 2023

article thumbnail

Kellogg’s is going to war over Mexico’s nutrition label rules. A similar fight is coming to the U.S.

STAT

MEXICO CITY — Kellogg’s is waging a war here over Tigre Toño and Sam el Tucán. A 2019 policy requires companies that make unhealthy foods to include warning labels on the front of any boxes they sell in Mexico to educate consumers about things like excess sugar and fat. Any food with a warning label — like Kellogg’s Fruit Loops or its Frosted Flakes, which typically contain more than 37 grams of added sugar in a 100-gram serving — is also banned from

Labelling 246
article thumbnail

Brii Biosciences aims to come up big where Sage and Biogen fell short

PharmaVoice

The depression space recently got a stinging FDA rebuke — but Brii thinks it can break through with improved formulations.

246
246
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

FDA approves Pfizer’s RSV vaccine designed to protect newborns by immunizing parent

STAT

The Food and Drug Administration on Monday approved a Pfizer vaccine that aims to protect newborns against RSV by vaccinating pregnant people in the latter part of pregnancy. The vaccine, Abrysvo, has also been approved for use in adults 60 and older to protect them against respiratory syncytial virus.

Vaccines 246
article thumbnail

Leveraging data to drive efficiency and patient-centricity in clinical trials

PharmaVoice

Using real-time data, patient centricity and personalized medicine to accelerate clinical trials.

246
246
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

STAT+: Intellia plays down concerns about accidental germline transmission in CRISPR trial

STAT

Earlier this month, Intellia Therapeutics announced it was scrapping plans to include U.S.-based sites in one of its mid-stage CRISPR trials after the Food and Drug Administration requested additional data to support including female patients of childbearing potential. The move left many researchers wondering whether the specter of accidental germline transmission — which haunted early gene therapy trials — had now risen over the field of gene editing.

Packaging 235
article thumbnail

SAEM Clinical Images Series: A Painful Swollen Digit

ALiEM - Pharm Pearls

A 50-year-old male with a history of polysubstance use disorder and poorly-controlled type 2 diabetes mellitus presents with left hand pain. One week ago, the patient sustained a macerating injury of the left distal middle digit. Since that time he has experienced worsening pain throughout the digit, now associated with diffuse swelling and discoloration.

Diabetes 130

More Trending

article thumbnail

The 2023-2024 Flu Season: What Pharmacists Need to Know

Digital Pharmacist

As we gear up for the upcoming flu season of 2023-2024, it’s important to reflect on the lessons of the previous year , and understand how the coming year may look different. In this article, we’ll delve into a comprehensive breakdown of the past season’s dynamics and provide valuable insights to equip you for the challenges and opportunities that lie ahead.

article thumbnail

STAT+: Pharmalittle: Regeneron wins a delayed approval; Bristol, J&J likely to face pricing negotiation

STAT

Good morning, everyone. Damian Garde here, filling in for Ed Silverman on yet another dog day of what has been a particularly canine summer. So begins another working week for those of us unlucky, unwise, or un-European enough to not be on a beach someplace. Here as always are a few items to get your day started. And if you hear anything curious out there, do let us know.

article thumbnail

UKHSA: No blanket restriction on private Covid vaccines

The Pharmacist

The UK Health Security Agency (UKHSA) has confirmed that it has not placed any restriction on the private sale of Covid vaccinations, meaning that manufacturers could agree deals with pharmacies to supply them. Community pharmacy leaders have said that they would welcome the opportunity to provide private Covid vaccinations for those that want them.

article thumbnail

STAT+: As the obesity drug market grows, digital health companies juggle patients and payers

STAT

To much of the public, the promise of telehealth is all about convenience — get the prescription you need quickly, and get it delivered right to your door. But as digital health companies build out their weight loss businesses, capitalizing on the popularity of drugs like Wegovy and Ozempic, they’re courting a very different audience: payers and employers who have a vested interest in preventing quick scripts.

Diabetes 204
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Strategies to Maximize Product Value Amid Loss of Exclusivity in the Pharmaceutical Industry

Drug Patent Watch

Loss of exclusivity (LOE) doesn’t have to spell doom for branded drug revenue streams. In the face of impending patent expirations, pharmaceutical companies can adopt key approaches to preserve meaningful… The post Strategies to Maximize Product Value Amid Loss of Exclusivity in the Pharmaceutical Industry appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

STAT+: Pharmalittle: Regeneron wins a delayed approval; Bristol, J&J likely to face pricing negotiation

STAT

Good morning, everyone. Damian Garde here, filling in for Ed Silverman on yet another dog day of what has been a particularly canine summer. So begins another working week for those of us unlucky, unwise, or un-European enough to not be on a beach someplace. Here as always are a few items to get your day started. And if you hear anything curious out there, do let us know.

article thumbnail

Respiratory symptoms linked to young people who vape

The Pharmacist

Use of vapes in teenagers and young adults is associated with an increased risk of wheeze, bronchitic symptoms and shortness of breath, a US study has concluded. The findings from a series of surveys, which began when participants were school pupils, remained when researchers controlled for smoking and second-hand smoke. More than 2000 Californian students […] The post Respiratory symptoms linked to young people who vape appeared first on The Pharmacist.

91
article thumbnail

An Inside Look into TransCelerate BioPharma

PharmExec

In this exclusive Q&A with Pharmaceutical Executive, Janice Chang, CEO of TransCelerate BioPharma, provides an inside look into her career journey, her work at the company, how the industry has changed in the last 10 years, as well as her thoughts on where the industry should put its efforts in clinical trials.

97
article thumbnail

FDA expands use of Neurocrine drug to Huntington’s patients

BioPharma Dive

Analysts expect the approval of Ingrezza in Huntington’s patients with a movement disorder known as chorea to intensify a commercial battle between Neurocrine and Teva.

97
article thumbnail

US FDA approves ABRYSVO, Pfizer’s maternal RSV vaccine for infants

Express Pharma

Pfizer announced that the US Food and Drug Administration (FDA) has approved ABRYSVO ( Respiratory Syncytial Virus Vaccine ), the company’s bivalent RSV prefusion F (RSVpreF) vaccine, for the prevention of LRTD and severe LRTD caused by RSV in infants from birth up to six months of age by active immunisation of pregnant individuals at 32 through 36 weeks gestational age.

article thumbnail

Global RNA therapy clinical trials market to reach $3.5 billion by 2030

European Pharmaceutical Review

According to a market report , the global RNA therapy clinical trials market is anticipated to reach $3.5 billion by 2030 and grow at a CAGR of 3.84 percent from 2023 to 2030. The data stated that expansion of the market in emerging countries is due to factors such as the rising success rate of RNA-based COVID-19 vaccines, regulatory approval, as well as demand for personalised medicines.

article thumbnail

Genesis raises $200 million for AI drug discovery research

BioPharma Dive

The Series B round brings the total funding for Genesis, a California startup backed by Andreessen Horowitz and Nvidia’s VC arm, to over $280 million.

97
article thumbnail

EC approves TECVAYLI’s reduced dosage frequency for multiple myeloma

Pharmaceutical Technology

The EC approved Janssen's Type II variation application for reduced dosing frequency of bispecific antibody TECVAYLI for multiple myeloma.

Dosage 98
article thumbnail

Regeneron rebounds to win FDA OK for longer-lasting vision loss drug

BioPharma Dive

The agency cleared high-dose Eylea less than two months after rejecting it, and approved a separate Regeneron drug for an ultra-rare disease as well.

98
article thumbnail

US FDA places partial clinical hold on Gilead’s studies on Magrolimab for AML treatment

Express Pharma

Gilead Sciences announced that the US Food and Drug Administration (FDA) has placed a partial clinical hold on the initiation of new patients in US studies evaluating magrolimab to treat acute myeloid leukemia (AML). The FDA action follows the previously announced discontinuation of the Phase 3 ENHANCE study of magrolimab in higher-risk myelodysplastic syndromes (HR-MDS).

88
article thumbnail

Biopharma sees strong Q2 2023 market cap growth

European Pharmaceutical Review

For 20 of the leading biopharmaceutical companies, the second quarter (Q2) of 2023 has brought an aggregate market capitalisation growth of 2.3 percent. Data and analytics company GlobalData has reported a rise from $3.49 trillion in the Q1 of 2023 to $3.56 trillion in Q2 2023. Q2 2023 biopharma market capitalisation results Eli Lilly “Eli Lilly witnessed the largest market capitalisation growth of 36.1 percent over Q2 2023, moving up to first position in the list and displacing Johnson & Jo

article thumbnail

Biden administration to urge Americans get COVID-19 boosters

Express Pharma

The Biden administration plans to urge all Americans to get a booster shot for the coronavirus this autumn to counter a new wave of infections, informed a White House official. The official said that while the Centers for Disease Control and Prevention are reporting an increase in infections and hospital admissions from the virus, overall levels remain low.

article thumbnail

Alligator Bioscience gains orphan designation for mitazalimab

Pharma Times

Mitazalimab is a monoclonal antibody that has been created to sensitize tumours to chemotherapy - News - PharmaTimes

article thumbnail

FDA partially halts leukemia studies of Gilead cancer drug

BioPharma Dive

The hold is the latest setback for a drug that was the center of Gilead’s $5 billion acquisition of biotech Forty Seven in 2020.

95
article thumbnail

Avantor inaugurates expanded Singapore hub

Express Pharma

Avantor, inaugurated its expanded Singapore Hub which includes a newly added cGMP manufacturing and a world class quality control laboratory. The hub is a one-stop facility serving the needs of customers across Asia, Middle East, and Africa (AMEA), strengthening the region’s innovation and biopharma ecosystems. A company statement informed that strategically located in Singapore, the hub enables quicker turnaround times and expedites customers’ access to raw materials that are essential in AMEA’

article thumbnail

FDA grants approval to Regeneron Pharmaceuticals’ EYLEA HD injection

Pharmaceutical Technology

The US Food and Drug Administration (FDA) has granted approval to Regeneron Pharmaceuticals’ EYLEA HD injection 8 mg.

98
article thumbnail

FDA 'recognises potential' of Redx drug to treat idiopathic pulmonary fibrosis

Outsourcing Pharma

The US Food and Drug Administration (FDA) has given orphan drug designation (ODD) to Redxâs Zelasudil for the potential treatment of idiopathic pulmonary fibrosis (IPF).

72
article thumbnail

AI drug discovery company Genesis Therapeutics wins $200m in Series B round

Pharmaceutical Technology

The company’s generative and predictive AI-powered drug discovery platform is already being used by Eli Lilly.

98
article thumbnail

FDA approves Pfizer’s RSV vaccine for use in pregnancy

BioPharma Dive

The expanded approval follows the FDA’s May clearance of the shot, called Abrysvo, in older adults.

article thumbnail

LEO receives marketing authorisation application for delgocitinib

Pharma Times

The treatment is indicated for adults with moderate-to-severe chronic hand eczema - News - PharmaTimes

87
article thumbnail

5 ways experience matters in gene therapy manufacturing

BioPharma Dive

By partnering with an accomplished CTDMO, gene therapy innovators can benefit from guidance and support.

98
article thumbnail

Novartis cites strong sales growth for $15B Sandoz spin-off as board vote unanimously for separation

Outsourcing Pharma

Novartisâ board of directors has unanimously agreed to separate Sandoz as a 100 per cent spin-off with a $15 billion share buyback.

72
article thumbnail

DNA repair discoveries hold promise for new approaches to cancer treatment

World Pharma News

DNA can be damaged by toxins, radiation, or even normal cell division, but human cells must continually fix DNA breaks to survive. In cells that cannot repair DNA effectively, changes (mutations) can occur that lead to cancer. Most cells rely on a system called homologous recombination or HR, which uses proteins called BRCA1 and BRCA2 for accurate DNA repair.

63
article thumbnail

'Virtual wards' for respiratory infections backed by NICE

pharmaphorum

'Virtual wards' for respiratory infections backed by NICE Phil.

93